Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 3, 2008, Pages 353-363

  Tsoi, K K F ^a   Ng, S S M ^a   Leung, M C M ^a   J y sung, J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIA; CANCER INCIDENCE; CANCER SCREENING; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; OCCULT BLOOD TEST; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

EID: 64649088501     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.0269-2813.2008.03726.x     Document Type: Article

References (45)

1. Sung JJY, Lau JYW, Goh KL, et al. Asia Pacific Working Group on Colorectal Cancer. Lancet Oncol 2005; 6: 871-6.
2. Sung JJY, FKL Chan, Leung WK, et al. Screening for Colorectal Neoplasms in Chinese: fecal occult blood test, Flexible Sigmoidoscopy or Colonoscopy? Gastroenterology 2003; 124: 608-14.
3. Choe JW, Chang HS, Yang SK, et al. Screening colonoscopy in asymptomatic average-risk Koreans: analysis in relation to age and sex. J Gastroenterol Hepatol 2007; 22: 1003-8.
4. Chiu HM, Wang HP, Lee YC, et al. A prospective study of the frequency and topographic distribution of colon neo-plasia in asymptomatic average-risk Chinese adults as determined by colono- scopic screening. Gastrointest Endosc 2005; 61: 547-53.
5. Leung WK, Ho KY, Kim WH, et al.Colo-rectal neoplasia in Asia: a multicenter
6. colonoscopy survey in symptomatic patients. GIE 2006; 64: 751-9.
7. Byeon JS, Yang SK, Kim TI, etal.Colo-rectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. GIE 2007; 65: 1015-22.
8. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G for Veterans Affairs Cooperative Study Group 380. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000; 343: 162-8.
9. Imperiale TF, Wagner DR, Lin CY, Lar- kin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasm in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-74.
10. Schoenfeld P, Cash B, Flood A, et al. CONCeRN Study Investigators. Colonoscopic screening of average-risk women for colorectal neoplasia. NEJM 2005; 352: 2061-8.
11. Betes M, Munoz-Navas MA, Duque JM, Anqos R, Macias E, et al Use of colo- noscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003; 98: 2648-54.
12. Sung JJ, Lau JY, Young GP, et al. Asia- Pacific consensus recommendations for colorectal cancer screening. Gut 2008; in press.
13. Sonnenberg A, Delco F, Inadomi J M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 573-84.
14. McGrath JS, Ponich TP, Gregor JC. Screening for colorectal cancer: the cost to finding an advanced adenoma. Am J Gastroenterol 2002; 97: 2902-7.
15. Frazier A L, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-61.
16. McMahon PM, Bosch J L, Gleason S, Halpern EF, Lester EF, Gazelle GS. Cost- effectiveness of colorectal cancer. Radiology 2001; 219: 44-50.
17. Li SR, Wang HH, Hu JC, etal. Comparison of three FOBT protocols for colorec- tal cancer screening in Chinese - a multicenter study. Chin Med J 2005; 85: 697-700.
18. Cheng TI, Wong JM, Hong CF, et al. Colorectal cancer screening in asympto- maic adults: comparison of colonos-copy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc 2002; 101: 685-90.
19. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum 2000; 43: S78-84.
20. Soon MS, Kozarek RA, Ayub K, Soon A, Lin TY, Lin OS. Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol 2005; 100: 2749-55.
21. Hou SI, Chen PH. Home-administered fecal occult blood test for colorectal cancer screening among worksites in Taiwan. Prev Med 2004; 38: 78-84.
22. Yang KC, Liao CS, Chiu YH, Yen AM, Chen TH. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen 2006; 13: S8-13.
23. Li S, Nie Z, Li N, et al. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study. Chin Med J 2003; 116: 200-2.
24. Hui AJ, Wong RM, Ching JY, Hung L C, Chung SC, Sung J J. Risk of colonoscop- i c polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004; 59: 44-8.
25. Wu GH, Wang YM, Yen AM, etal. Cost-effectiveness analysis of CRC screening with stool DNA testing in intermediate- incidence countries. BMC Cancer 2006; 6: 136.
26. Levin B, Lieberman DA, McFarland B, etal. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastro-enterology 2008; in press.
27. Hospital Authority: Hong Kong Cancer Registry Web Site. Available at: http:// www.ha.org.hk/cancereg (accessed May 2007)
28. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S. Japan Public Health Center- based Prospective Study. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev 2007; 31:3-11.
29. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by col- onoscopic polypectomy. New Engl J Med 1993; 329: 1977-81.
30. Kemeny N. Presurgical chemotherapy in patients being considered for liver resection. Oncologist 2007; 12: 825-39.
31. Borner MM. Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer - too good to be true? Ann Oncol 1999; 10: 623-6.
32. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leu- covorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 234-351.
33. Bir A, Tan W, Wilding GE, Lombardo J, Fakih MG. 5-Fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colo- rectal cancer: a single-institute study. Oncology 2007; 72: 4-9.
34. Omura K. Advances in chemotherapy against advanced or metastatic colorectal cancer. Digestion 2008; 77(S1): 13-22.
35. Hospital Authority: List of Charges: S.S. No. 4 to Gazette No.44/1996. Hong Kong, People's Republic of China: Government Printers, 1996, 2003.
36. Leung KL, Kwok SP, Lam SC, et al. Lap- aroscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 2004; 363: 1187-92.
37. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313: 275-83.
38. Hong Kong Census and statistics Department: Hong Kong Life Tables 1996-2031. Hong Kong, People's Republic of China: Government of the Hong Kong Special Administrative Region, Government Printers, 2004.
39. Li S, Wang H, Hu J, et al. New immuno-chemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients. Int JCancer 2006; 118: 3078-83.
40. Kahi C J, Azzouz F, Juliar BE, Imperiale TF. Survival of elderly persons undergoing colonoscopy: implications of colo- rectal cancer screening and surveillance. Gastrointest Endosc 2007; 66: 544-50.
41. Lin OS, Kozarek RA, Schembre DB, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA 2006; 295: 2357-65.
42. Salkeld G, Young G, Irwiq L, Haas M, Glasziou P. Cost-effectiveness analysis of screening by fecal occult blood testing for colorectal cancer in Australia. Aust NZ J Public Health 1996; 20: 138-43.
43. Mendal JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. NEngl JMed 1993; 328: 1365-71.
44. Wong SS, Leong AP, Leong TY. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach. Medinfo 2004; 11: 104-10.
45. Park SM, Yun YH, Kwon S. Feasible economic strategies to improve screening compliance for colorectal cancer in Korea. World J Gastroenterol 2005; 11: 1587-93.